{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T19:42:15Z","timestamp":1782330135209,"version":"3.54.5"},"reference-count":33,"publisher":"European Respiratory Society (ERS)","issue":"4","license":[{"start":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T00:00:00Z","timestamp":1627516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001511","name":"Auckland Medical Research Foundation","doi-asserted-by":"publisher","award":["Grant 3110015"],"award-info":[{"award-number":["Grant 3110015"]}],"id":[{"id":"10.13039\/501100001511","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2021,7,9]]},"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:p>Sputum procalcitonin is elevated in exacerbations of bronchiectasis. The primary aim of this study was to investigate whether sputum procalcitonin levels are higher in patients with stable bronchiectasis than in healthy controls. We also assessed differences in procalcitonin levels in spontaneously expectorated and induced sputum samples and their repeatability 1\u2005week later.<\/jats:p><jats:p>Participants included were aged over 18\u2005years and either had radiologically confirmed bronchiectasis or were healthy controls. Patients with bronchiectasis were clinically stable for at least 6\u2005weeks and had spontaneous and induced sputum collected at visit 1 and again 7\u2005days later. Only induced sputum samples were collected from healthy controls during visit 1. Sputum procalcitonin concentrations in sputum were measured.<\/jats:p><jats:p>In total, 30 patients with bronchiectasis and 15 healthy controls were enrolled in this observational study. In the pooled data from visit 1 and 2, the geometric mean procalcitonin level in induced sputum was significantly higher in the bronchiectasis group than in the healthy control group (1.5\u2005ng\u00b7mL<jats:sup>\u22121<\/jats:sup>, 95% CI 1.0\u20132.1 ng\u00b7mL<jats:sup>\u22121<\/jats:sup><jats:italic>versus<\/jats:italic>0.4\u2005ng\u00b7mL<jats:sup>\u22121<\/jats:sup>, 95% CI 0.2\u20130.9\u2005ng\u00b7mL<jats:sup>\u22121<\/jats:sup>; mean ratio 3.6, 95% CI 1.5\u20138.6; p<jats:italic>=<\/jats:italic>0<jats:italic>.<\/jats:italic>006). Mean procalcitonin level was higher in spontaneous sputum than in induced sputum at visit 1 (1.8\u2005ng\u00b7mL<jats:sup>\u22121<\/jats:sup>, 95% CI 1.2\u20132.7 ng\u00b7mL<jats:sup>\u22121<\/jats:sup><jats:italic>versus<\/jats:italic>1.1\u2005ng\u00b7mL<jats:sup>\u22121<\/jats:sup>, 95% CI 0.7\u20131.8\u2005ng\u00b7mL<jats:sup>\u22121<\/jats:sup>) and visit 2 (1.5\u2005ng\u00b7mL<jats:sup>\u22121<\/jats:sup>, 95% CI 1.0\u20132.5\u2005ng\u00b7mL<jats:sup>\u22121<\/jats:sup><jats:italic>versus<\/jats:italic>1.2\u2005ng\u00b7mL<jats:sup>\u22121<\/jats:sup>, 95% CI 0.8\u20131.6\u2005ng\u00b7mL<jats:sup>\u22121<\/jats:sup>; p=0.001). Repeating spontaneous and induced sputum procalcitonin levels 1\u2005week later produced similar concentrations (p=0.29, intraclass correlation coefficient (ICC)=0.76 and p<jats:italic>=<\/jats:italic>0.72, ICC=0.70, respectively).<\/jats:p><jats:p>Sputum procalcitonin is increased in patients with stable bronchiectasis and has potential as a biomarker of airway inflammation and infection in bronchiectasis.<\/jats:p>","DOI":"10.1183\/23120541.00285-2021","type":"journal-article","created":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T14:40:18Z","timestamp":1627569618000},"page":"00285-2021","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Sputum procalcitonin: a potential biomarker in stable bronchiectasis"],"prefix":"10.1183","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2656-1127","authenticated-orcid":false,"given":"William","family":"Good","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8100-3120","authenticated-orcid":false,"given":"Irene","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louanne","family":"Storey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Mooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lata","family":"Jayaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conroy","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2021,7,29]]},"reference":[{"key":"2024101711172214000_7.4.00285-2021.1","doi-asserted-by":"crossref","unstructured":"Men\u00e9ndez R , Sibila O . Pathophysiology, immunology, and histopathology of bronchiectasis. In: Bronchiectasis. New York, Springer, 2018; pp. 51\u201364.","DOI":"10.1007\/978-3-319-61452-6_5"},{"key":"2024101711172214000_7.4.00285-2021.2","doi-asserted-by":"crossref","unstructured":"Boaventura R , Shoemark A , Chalmers J . Pathophysiology. In: Chalmers J , Polverino E , Aliberti S , eds. Bronchiectasis (ERS Monograph). Sheffield, European Respiratory Society, 2018; pp. 8\u201328.","DOI":"10.1183\/2312508X.10021218"},{"key":"2024101711172214000_7.4.00285-2021.3","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201309-1575OC"},{"key":"2024101711172214000_7.4.00285-2021.4","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1164\/rccm.201711-2202OC","article-title":"Characterization of the \u201cfrequent exacerbator phenotype\u201d in bronchiectasis","volume":"197","author":"Chalmers","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101711172214000_7.4.00285-2021.5","doi-asserted-by":"crossref","first-page":"28596426","DOI":"10.1183\/13993003.00051-2017","article-title":"Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research","volume":"49","author":"Hill","year":"2017","journal-title":"Eur Respir J"},{"key":"2024101711172214000_7.4.00285-2021.6","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-0490"},{"key":"2024101711172214000_7.4.00285-2021.7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021444"},{"key":"2024101711172214000_7.4.00285-2021.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00433.x"},{"key":"2024101711172214000_7.4.00285-2021.9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.1.396"},{"key":"2024101711172214000_7.4.00285-2021.10","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-012-0439-5"},{"key":"2024101711172214000_7.4.00285-2021.11","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aen073"},{"key":"2024101711172214000_7.4.00285-2021.12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00011-010-0255-8","article-title":"Exogenous procalcitonin evokes a pro-inflammatory cytokine response","volume":"60","author":"Liappis","year":"2011","journal-title":"Inflamm Res"},{"key":"2024101711172214000_7.4.00285-2021.13","first-page":"595","article-title":"Procalcitonin: how a hormone became a marker and mediator of sepsis","volume":"131","author":"Muller","year":"2001","journal-title":"Swiss Med Wkly"},{"key":"2024101711172214000_7.4.00285-2021.14","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-9-107"},{"key":"2024101711172214000_7.4.00285-2021.15","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1002\/hsr2.203","article-title":"Sputum procalcitonin levels in patients admitted to hospital with acute exacerbations of bronchiectasis","volume":"3","author":"Good","year":"2020","journal-title":"Health Sci Rep"},{"key":"2024101711172214000_7.4.00285-2021.16","doi-asserted-by":"publisher","DOI":"10.1177\/1479972308088823"},{"key":"2024101711172214000_7.4.00285-2021.17","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1080\/15412555.2017.1286171","article-title":"Bronchiectasis: phenotyping a complex disease","volume":"14","author":"Chalmers","year":"2017","journal-title":"COPD"},{"key":"2024101711172214000_7.4.00285-2021.18","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00034805"},{"key":"2024101711172214000_7.4.00285-2021.19","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.158.1.9705031"},{"key":"2024101711172214000_7.4.00285-2021.20","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.02.00001902"},{"key":"2024101711172214000_7.4.00285-2021.21","doi-asserted-by":"crossref","first-page":"1s","DOI":"10.1183\/09031936.02.00000102","article-title":"Standardised methodology of sputum induction and processing","volume":"20","author":"Djukanovi\u0107","year":"2002","journal-title":"Eur Respir J"},{"key":"2024101711172214000_7.4.00285-2021.22","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.56.5.366"},{"key":"2024101711172214000_7.4.00285-2021.23","first-page":"A1440","article-title":"Bronko Test sputum colour as a marker of neutrophilic bronchitis in adults with asthma.","volume":"193","author":"Sim pson","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101711172214000_7.4.00285-2021.24","doi-asserted-by":"publisher","DOI":"10.1210\/jc.79.6.1605"},{"key":"2024101711172214000_7.4.00285-2021.25","doi-asserted-by":"crossref","unstructured":"Good W , Lata J , Vandal A , et al. How do we know what works? Clinical trial end-points and quality of life assessment. In: Chalmers J , Polverino E , Aliberti S , eds. Bronchiectasis (ERS Monograph). Sheffield, European Respiratory Society, 2018; pp. 99\u2013132.","DOI":"10.1183\/2312508X.10015717"},{"key":"2024101711172214000_7.4.00285-2021.26","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201605-1027OC"},{"key":"2024101711172214000_7.4.00285-2021.27","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.4.337"},{"key":"2024101711172214000_7.4.00285-2021.28","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-014-0138-6"},{"key":"2024101711172214000_7.4.00285-2021.29","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.154.4.8887576"},{"key":"2024101711172214000_7.4.00285-2021.30","doi-asserted-by":"publisher","DOI":"10.1136\/thx.52.6.498"},{"key":"2024101711172214000_7.4.00285-2021.31","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/14737159.2017.1324299","article-title":"Overview of procalcitonin assays and procalcitonin-guided protocols for the management of patients with infections and sepsis","volume":"17","author":"Schuetz","year":"2017","journal-title":"Expert Rev Mol Diagn"},{"key":"2024101711172214000_7.4.00285-2021.32","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1183\/20734735.000218","article-title":"Gender differences in bronchiectasis: a real issue?","volume":"14","author":"Vidaillac","year":"2018","journal-title":"Breathe (Sheff)"},{"key":"2024101711172214000_7.4.00285-2021.33","first-page":"OA1969","article-title":"Sputum pregnancy zone protein (PZP) \u2013 a potential biomarker of bronchiectasis severity","volume":"50","author":"Smith","year":"2017","journal-title":"Eur Respir J"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00285-2021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:11:33Z","timestamp":1740373893000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00285-2021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,29]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,10,25]]},"published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.1183\/23120541.00285-2021"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00285-2021","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,29]]}}}